300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
InsurTech
Platforms
Oil and Gas
Retail
Social Impact
Film
Cryptocurrency
SaaS
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Social Network
Blockchain
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Venture Capital
Web3
Fashion
Cannabis
LGBT
Social
Celebrity
Climate
Beauty
Mobile Apps
Life Science
Infrastructure
Wine and Spirits
Food and Beverage
Publishing
Music
Manufacturing
Digital Media
FinTech
Art
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Real Estate
Transportation
Enterprise
Community
Media (Entertainment)
Sporting Goods
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Mexico
Nigeria
Tajikistan
Russian Federation
Togo
Guinea
Iran
Nepal
Isle of Man
Pakistan
Madagascar
Poland
Romania
Oman
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
Armenia
China
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Mauritius
Namibia
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Morocco
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Turkey
Myanmar
Uganda
Uruguay
Seychelles
Moldova
Botswana
Ireland
Paraguay
Japan
South Africa
France
Canada
Georgia
Denmark
Ghana
United Kingdom
Iraq
Mali
Latvia
Malaysia
Portugal
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Philippines
Germany
India
United States
Indonesia
Middle East
Asia
Dominican Republic
Bermuda
Albania
Argentina
Spain
Angola
Europe
Cyprus
Bangladesh
Qatar
Belgium
Barbados
Jordan
Austria
Azerbaijan
Ethiopia
Bahamas
Bulgaria
Faroe Islands
Estonia
Ecuador
Bolivia
Jersey
Bahrain
Algeria
Belize
Finland
Hungary
Italy
Grenada
Israel
Belarus
Iceland
Liechtenstein
Cambodia
Honduras
Lebanon
Lithuania
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Jaivir Pall, Founder & Partner at Harbr

Jaivir Pall

Founder & Partner @ Harbr

London, United Kingdom

Jaivir Pall is a seed investor at Harbr in London focused on Wellness and Health Care. Jaivir Pall is the Board of Directors of Abvance Therapeutics. With a background in investment banking, finance, business development, and data science, Jai is a multi-disciplinary commercial leader. He assists startups in improving their commercial and financial models as well as preparing for investment. Jai lives with type 1 diabetes who alsohappens to be an expert in the subject. He consults with startups, corporations, and regulators on diabetes-related research and technology on a regular basis. He was instrumental in the establishment of Pathfinder Health in India, working alongside Dr Niti Pall. After that, he worked for KPMG in India before moving to the UK and becoming the commercial lead for Practice Unbound, a company that was extremely successful in providing services to NHS England and Wales.

Total investments:
1
Last investment:
Lead investor:
100%

Last updated:

Industries Jaivir Pall invests in

WellnessHealth CareTherapeuticsPersonal Health

Stages Jaivir Pall invests in

Seed

Countries Jaivir Pall invests in

United States

Investment Focus

Industry

  • Wellness 1 (100%)
  • Health Care 1 (100%)
  • Therapeutics 1 (100%)
  • Personal Health 1 (100%)

Investments

CompanyDescriptionRoundLinks
Abvance Therapeutics Abvance Therapeutics
Abvance Therapeutics is a biotechnology research company that focuses on innovative solutions to address unmet needs in diabetes care. The company is known for developing a novel coformulation of insulin and glucagon, which could revolutionize diabetes care. This treatment combines two well-understood and FDA-approved peptides to control glycemiawhile mitigating the threat of hypoglycemia. The company's team of scientists and physicians have discovered this unique approach to diabetes treatment, aiming to reduce hypoglycemia and improve patient outcomes. Seed / Jun 24, 2025
Harbr

About Harbr

VC Fund · London, United Kingdom

Harbr is an accelerator and venture builder for health technology businesses.

Harbr Contacts

NameEmailPhoneSocials
Jaivir Pall
Jaivir Pall Founder & Partner
Omar Daniel
Omar Daniel Co-founder & Partner

Sign up to unlock verified contacts

Unlock Contacts

3 more contacts available

Open Harbr full profile

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
InsurTech
Platforms
Oil and Gas
Retail
Social Impact
Film
Cryptocurrency
SaaS
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Social Network
Blockchain
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Venture Capital
Web3
Fashion
Cannabis
LGBT
Social
Celebrity
Climate
Beauty
Mobile Apps
Life Science
Infrastructure
Wine and Spirits
Food and Beverage
Publishing
Music
Manufacturing
Digital Media
FinTech
Art
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Real Estate
Transportation
Enterprise
Community
Media (Entertainment)
Sporting Goods
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Mexico
Nigeria
Tajikistan
Russian Federation
Togo
Guinea
Iran
Nepal
Isle of Man
Pakistan
Madagascar
Poland
Romania
Oman
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
Armenia
China
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Mauritius
Namibia
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Morocco
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Turkey
Myanmar
Uganda
Uruguay
Seychelles
Moldova
Botswana
Ireland
Paraguay
Japan
South Africa
France
Canada
Georgia
Denmark
Ghana
United Kingdom
Iraq
Mali
Latvia
Malaysia
Portugal
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Philippines
Germany
India
United States
Indonesia
Middle East
Asia
Dominican Republic
Bermuda
Albania
Argentina
Spain
Angola
Europe
Cyprus
Bangladesh
Qatar
Belgium
Barbados
Jordan
Austria
Azerbaijan
Ethiopia
Bahamas
Bulgaria
Faroe Islands
Estonia
Ecuador
Bolivia
Jersey
Bahrain
Algeria
Belize
Finland
Hungary
Italy
Grenada
Israel
Belarus
Iceland
Liechtenstein
Cambodia
Honduras
Lebanon
Lithuania
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Jaivir Pall invest in?

Jaivir Pall invests primarily in Wellness, Health Care and Therapeutics startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did Jaivir Pall last invest?

The most recent investment recorded for Jaivir Pall closed in Jun 2025. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Jaivir Pall Jaivir Pall Find email